Professor Adrian Towse is Director Emeritus and Senior Research Fellow of the Office of Health Economics in the UK. Adrian’s current research includes incentives for new drugs and vaccines to tackle Antimicrobial Resistance, the use of ‘risk-sharing’ arrangements between health care payers and pharmaceutical companies, including value-based pricing approaches; the economics of pharmacogenetics for health care payers and the pharmaceutical industry; economic issues that affect both R&D for and access to treatments for diseases prevalent in the developing world; the economics of medical negligence; and measuring productivity in health care.
A visiting Professor at the London School of Economics and a Senior Researcher at the Nuffield Department of Population Health at the University of Oxford, Adrian also has been a Visiting Professor at the University of York. For ten years, he served as the Non-Executive Director of the Oxford Radcliffe Hospitals NHS Trust, one of the UK’s largest hospitals. Adrian was President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), for the 2014-15 term.
Adrian joined the OHE in 1993 and served as Director for 25 years. He holds an MA (Hons) in Politics, Philosophy and Economics from Keble College, Oxford; an MPhil in Management Studies from Nuffield College, Oxford, and the Oxford Centre for Management Studies; and is a Member of the Chartered Institute of Management Accountants.
SPEAKER: EXPLORING VALUE: NOVEL ELEMENTS FOR BREAKTHROUGH TREATMENTS; ADAPTIVE PATHWAYS: GENERATING EVIDENCE OF VALUE; INNOVATION FOR SMALL POPULATIONS: WHAT SHOULD WE PAY FOR?